Filed: 8/14/2026ACC: 0002050709-26-000027
📋 What this filing means
SQUADRON CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $322.25M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$322.25M
Total AUM (reported)
44.28M
Total Shares
Allocation by class
COM$209.22M64.9%
COM STK$35.49M11.0%
COM NEW$26.52M8.2%
SPONSORED ADS$17.36M5.4%
ADS$14.45M4.5%
COM SHS$8.28M2.6%
CL A$4.26M1.3%
Portfolio Concentration
Top 3$119.83M37.2%
4–10$98.55M30.6%
11–25$86.27M26.8%
Rest$17.59M5.5%
Top 3 weight
37.2%
Top 10 weight
67.8%
Voting Authority Distribution
Total shares with voting rights: 44.28M
Sole
Full voting authority
41.69M
shares
% of voting shares94.2%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
2.59M
shares
% of voting shares5.8%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 94.2% of voting shares
Institutional Holdings38
Rows:
RELMADA THERAPEUTICS INC
SOLEShares7.35M
TypeSH
Market value$50.86M
15.78%
Sole
7.35M
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares7.60M
TypeSH
Market value$35.49M
11.01%
Sole
7.20M
Shared
0.00
None
400K
COGENT BIOSCIENCES INC
SOLEShares865K
TypeSH
Market value$33.48M
10.39%
Sole
865K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC
SOLEShares4.13M
TypeSH
Market value$20.01M
6.21%
Sole
3.70M
Shared
0.00
None
426K
KODIAK SCIENCES INC
SOLEShares500K
TypeSH
Market value$19.48M
6.05%
Sole
500K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares970K
TypeSH
Market value$18.15M
5.63%
Sole
970K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares290K
TypeSH
Market value$11.78M
3.66%
Sole
290K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares335K
TypeSH
Market value$10.00M
3.10%
Sole
335K
Shared
0.00
None
0.00
BIOAGE LABS INC
SOLEShares405K
TypeSH
Market value$9.93M
3.08%
Sole
155K
Shared
0.00
None
250K
INVENTIVA SA
SOLEShares2.44M
TypeSH
Market value$9.20M
2.86%
Sole
2.44M
Shared
0.00
None
0.00
ADLAI NORTYE LTD
SOLEShares764.88K
TypeSH
Market value$8.80M
2.73%
Sole
764.88K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares605K
TypeSH
Market value$8.56M
2.66%
Sole
300K
Shared
0.00
None
305K
ENLIVEN THERAPEUTICS INC
SOLEShares160K
TypeSH
Market value$8.12M
2.52%
Sole
160K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.30M
TypeSH
Market value$6.78M
2.10%
Sole
403.41K
Shared
0.00
None
900K
ARRIVENT BIOPHARMA INC
SOLEShares183K
TypeSH
Market value$6.36M
1.97%
Sole
0.00
Shared
0.00
None
183K
PALISADE BIO INC
SOLEShares3M
TypeSH
Market value$6.27M
1.95%
Sole
3M
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3M
TypeSH
Market value$6.09M
1.89%
Sole
3M
Shared
0.00
None
0.00
ADAGENE INC
SOLEShares1.25M
TypeSH
Market value$5.25M
1.63%
Sole
1.25M
Shared
0.00
None
0.00
FORTE BIOSCIENCES INC
SOLEShares225K
TypeSH
Market value$4.78M
1.48%
Sole
225K
Shared
0.00
None
0.00
INFLARX NV
SOLEShares2M
TypeSH
Market value$4.48M
1.39%
Sole
2M
Shared
0.00
None
0.00
ASSEMBLY BIOSCIENCES INC
SOLEShares160K
TypeSH
Market value$4.40M
1.36%
Sole
160K
Shared
0.00
None
0.00
PROMIS NEUROSCIENCES INC
SOLEShares324.98K
TypeSH
Market value$4.28M
1.33%
Sole
324.98K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares260K
TypeSH
Market value$4.26M
1.32%
Sole
260K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares85K
TypeSH
Market value$4.00M
1.24%
Sole
85K
Shared
0.00
None
0.00
SOL-GEL TECHNOLOGIES LTD
SOLEShares52K
TypeSH
Market value$3.86M
1.20%
Sole
52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS INCSOLE | COM | 7.35M | SH | $50.86M 15.78% | 7.35M | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 7.60M | SH | $35.49M 11.01% | 7.20M | 0.00 | 400K |
COGENT BIOSCIENCES INCSOLE | COM | 865K | SH | $33.48M 10.39% | 865K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 4.13M | SH | $20.01M 6.21% | 3.70M | 0.00 | 426K |
KODIAK SCIENCES INCSOLE | COM | 500K | SH | $19.48M 6.05% | 500K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 970K | SH | $18.15M 5.63% | 970K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 290K | SH | $11.78M 3.66% | 290K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 335K | SH | $10.00M 3.10% | 335K | 0.00 | 0.00 |
BIOAGE LABS INCSOLE | COM | 405K | SH | $9.93M 3.08% | 155K | 0.00 | 250K |
INVENTIVA SASOLE | ADS | 2.44M | SH | $9.20M 2.86% | 2.44M | 0.00 | 0.00 |
ADLAI NORTYE LTDSOLE | SPONSORED ADS | 764.88K | SH | $8.80M 2.73% | 764.88K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 605K | SH | $8.56M 2.66% | 300K | 0.00 | 305K |
ENLIVEN THERAPEUTICS INCSOLE | COM | 160K | SH | $8.12M 2.52% | 160K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.30M | SH | $6.78M 2.10% | 403.41K | 0.00 | 900K |
ARRIVENT BIOPHARMA INCSOLE | COM | 183K | SH | $6.36M 1.97% | 0.00 | 0.00 | 183K |
PALISADE BIO INCSOLE | COM | 3M | SH | $6.27M 1.95% | 3M | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3M | SH | $6.09M 1.89% | 3M | 0.00 | 0.00 |
ADAGENE INCSOLE | ADS | 1.25M | SH | $5.25M 1.63% | 1.25M | 0.00 | 0.00 |
FORTE BIOSCIENCES INCSOLE | COM NEW | 225K | SH | $4.78M 1.48% | 225K | 0.00 | 0.00 |
INFLARX NVSOLE | COM | 2M | SH | $4.48M 1.39% | 2M | 0.00 | 0.00 |
ASSEMBLY BIOSCIENCES INCSOLE | COM NEW | 160K | SH | $4.40M 1.36% | 160K | 0.00 | 0.00 |
PROMIS NEUROSCIENCES INCSOLE | COM SHS | 324.98K | SH | $4.28M 1.33% | 324.98K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 260K | SH | $4.26M 1.32% | 260K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 85K | SH | $4.00M 1.24% | 85K | 0.00 | 0.00 |
SOL-GEL TECHNOLOGIES LTDSOLE | SHS NEW | 52K | SH | $3.86M 1.20% | 52K | 0.00 | 0.00 |
Page 1 of 2